Provided by Tiger Trade Technology Pte. Ltd.

Beta Bionics, Inc.

17.43
-0.6500-3.60%
Volume:1.11M
Turnover:19.38M
Market Cap:776.71M
PE:-10.57
High:18.04
Open:17.96
Low:17.07
Close:18.08
52wk High:32.71
52wk Low:8.80
Shares:44.56M
Float Shares:26.52M
Volume Ratio:1.18
T/O Rate:4.20%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.6486
EPS(LYR):-1.8100
ROE:-26.16%
ROA:-16.67%
PB:3.03
PE(LYR):-9.63

Loading ...

Beta Bionics, - Mint Full U.S. Commercialization Expected to Begin in Q1 2027

THOMSON REUTERS
·
Sep 14

Beta Bionics, Inc.: During FY 2027, Expects Mint to Recapture Any Revenue Lost in Q4 2026

THOMSON REUTERS
·
Sep 14

Senseonics Partners with Beta Bionics to Integrate Eversense 365 CGM with iLet Bionic Pancreas

Reuters
·
Sep 14

Senseonics Holdings: Development of Eversense 365-Ilet Integration Expected to be Completed in Q4 2026

THOMSON REUTERS
·
Sep 14

Senseonics Announces Strategic Partnership with Beta Bionics to Integrate Eversense® 365 with the Ilet® Bionic Pancreas

THOMSON REUTERS
·
Sep 14

Beta Bionics (BBNX) Faces Securities Lawsuit After iLet Patient-Start Miss and FDA-Related Disclosures

TIPRANKS
·
Sep 11

Beta Bionics Chief Commercial Officer Mark Hopman Disposes of 36,870 Common Shares Worth $680,723.44

Reuters
·
Sep 11

Beta Bionics CEO Sean Saint Disposes of 5,641 Common Shares for $113,261.01

Reuters
·
Sep 05

Beta Bionics Initiated at Market Perform by William Blair

Dow Jones
·
Aug 22

Beta Bionics price target raised to $18 from $15.50 at BofA

TIPRANKS
·
Aug 11

BofA Securities Adjusts Beta Bionics Price Target to $18 From $15.50

MT Newswires Live
·
Aug 11

Dexcom Q2 Revenue Beats Estimates Raises Outlook; Raises FY Revenue and Margin Guidance

Reuters
·
Jul 31

Beta Bionics price target lowered to $30.40 from $32 at Ladenburg

TIPRANKS
·
Jul 30

Analysts Are Bullish on Top NA Stocks: Waystar Holding Corp. (WAY), Beta Bionics, Inc. (BBNX)

TIPRANKS
·
Jul 30

Beta Bionics Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Jul 30

Beta Bionics Q2 FY26 Net Loss Widens 39% to $23.4 Million; Net Sales Climb 38% to $32 Million

Reuters
·
Jul 30

Beta Bionics reports Q2 EPS (53c), consensus (56c)

TIPRANKS
·
Jul 30

Beta Bionics backs FY26 revenue view $131M-$136M, consensus $133.48M

TIPRANKS
·
Jul 30

Beta Bionics Q2 Sales Beat Estimates on Pharmacy Channel Growth

Reuters
·
Jul 30

Beta Bionics Q2 EPS $(0.53) Beats $(0.56) Estimate, Sales $32.013M Beat $31.443M Estimate

Benzinga Earnings
·
Jul 30